Source document or public record
FDA 510(k) K221826 — BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)
FDA 510(k) index record K221826. Device: BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30). Applicant as listed: Becton, Dickinson and Company. Decision date: 2022-12-21.
Source
"device_name": "BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K221826.
Device name: BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30). Applicant as listed: Becton, Dickinson and Company.
Decision date: 2022-12-21. Decision wording: Substantially Equivalent.
Product code: JTN. Regulation: 21 CFR 866.1620. Medical specialty: Microbiology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.